Clinical Implications of Novel Genomic Discoveries in Chronic Lymphocytic Leukemia.

about

Diagnosis and classification of hematologic malignancies on the basis of genetics.Wnt signalling pathways in chronic lymphocytic leukaemia and B-cell lymphomas.Recent therapeutic advances in chronic lymphocytic leukemia.Critical molecular pathways in CLL therapy.

P2860

Q39363409-B60FB99F-5B08-4E31-BC56-2AAF1F87AE75 Q39432317-17860F17-EF46-4EA4-9304-FBADD3107A77 Q46318389-687D2951-4FAC-417A-A2AF-AFAF9414D0CF Q55447785-6CFCD301-1D65-4D3A-9E28-551CDCD7941D

P2860

Clinical Implications of Novel Genomic Discoveries in Chronic Lymphocytic Leukemia.

Item

http://www.wikidata.org/entity/Q38744632

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Clinical Implications of Novel Genomic Discoveries in Chronic Lymphocytic Leukemia.

@en

type

Item

label

Clinical Implications of Novel Genomic Discoveries in Chronic Lymphocytic Leukemia.

@en

prefLabel

Clinical Implications of Novel Genomic Discoveries in Chronic Lymphocytic Leukemia.

@en

P1476

Clinical Implications of Novel Genomic Discoveries in Chronic Lymphocytic Leukemia.

@en

P2093

Catherine J Wu

http://www.w3.org/2001/XMLSchema#string

Gregory Lazarian

http://www.w3.org/2001/XMLSchema#string

Romain Guièze

http://www.w3.org/2001/XMLSchema#string

P2860

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

Mutational heterogeneity in cancer and the search for new cancer-associated genes

Combination chemoimmunotherapy with pentostatin, cyclophosphamide, and rituximab shows significant clinical activity with low accompanying toxicity in previously untreated B chronic lymphocytic leukemia

The biology and clinical significance of acquired genomic copy number aberrations and recurrent gene mutations in chronic lymphocytic leukemia

Clonal evolution in hematological malignancies and therapeutic implications

Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-up.

TP53 mutation and survival in chronic lymphocytic leukemia.

Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation.

Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia.

The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial.

P304

984-993

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2016.71.0822

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28297623

http://www.w3.org/2001/XMLSchema#string

P921

lymphocyte

P932

5559883

http://www.w3.org/2001/XMLSchema#string

Clinical Implications of Novel Genomic Discoveries in Chronic Lymphocytic Leukemia.

about

P2860

P2860

Clinical Implications of Novel Genomic Discoveries in Chronic Lymphocytic Leukemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932